Table 3.
alloCTL ± relevant target glioma | T-cell subset phenotype | % of the total CD3+ cells | % of CD3+ subset also IFN-γ+ | IFN-γ MFI |
---|---|---|---|---|
alloCTL | CD3+/CD8+/CD69+ | 10.5% | 52.1% | 500 |
alloCTL + target glioma | CD3+/CD8+/CD69+ | 62.7% | 34.7% | 2543 |
alloCTL | CD3+/CD4+/CD69+ | 35.3% | 0.70% | 254 |
alloCTL + target glioma | CD3+/CD4+/CD69+ | 80.0% | 0.90% | 1605 |